Last reviewed · How we verify

NCT02737800: GnRh

Effect of Prolonged GnRh Agonist Therapy on the Outcome of In-Vitro Fertilization& Embryo Transfer in Endometrioma Patients

Completed NA Last updated 27 July 2018
What this trial tests

NA trial testing endometrioma aspiration in Endometrioma in 88 participants. Completed in 1 August 2017.

Timeline
1 April 2016
Primary endpoint
1 August 2017
1 August 2017

Quick facts

Lead sponsorKasr El Aini Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment88
Start date1 April 2016
Primary completion1 August 2017
Estimated completion1 August 2017
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kasr El Aini Hospital

Who can join

Adults 18 to 40, female only, with Endometrioma. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Investigators compare ICSI results for endometrioma patients with or without cyst aspiration if more than 5cm \&with or without GnRh agonists for all endometrioma patients

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.
    Georgiou EX, Melo P, Baker PE, Sallam HN, et al · · 2019 · cited 41× · PMID 31747470 · DOI 10.1002/14651858.cd013240.pub2

Verify or expand the search:

Other recruiting trials for Endometrioma

Currently open trials in the same condition.

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02737800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing